Work

P447 Vedolizumab induces significantly higher endoscopic remission rates at week 16 in ulcerative colitis as compared to Crohn's disease

Year: 2017

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjx002.572

Authors: R.W.M. Pauwels, A.C. De Vries, C.J. Van der Woude

Institution: Erasmus MC

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586941398

Cites:

Cited by: 2

Related to: 10